Publication:
Microrna dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics

Simple item page
dc.contributor.authorAksoy, Savaş
dc.contributor.authorKanat, Özkan
dc.contributor.authorTunca, Berrin
dc.contributor.authorErtaş, Hülya
dc.contributor.authorUğraş, Nesrin
dc.contributor.authorÖztürk, Erman
dc.contributor.authorYılmazlar, Tuncay
dc.contributor.authorÇeçener, Gülşah
dc.contributor.authorEgeli, Ünal
dc.contributor.authorYerci, Ömer
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Biyoloji Bölümü
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Bölümü
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Bölümü
dc.contributor.orcid0000-0002-1619-6680
dc.contributor.orcid0000-0002-5872-8825
dc.contributor.orcid0000-0002-1559-8047
dc.contributor.orcid0000-0002-3820-424X
dc.contributor.orcid0000-0001-7904-883X
dc.contributor.researcheridAAH-3847-2021
dc.contributor.researcheridAAH-2716-2021
dc.contributor.researcheridABI-6078-2020
dc.contributor.researcheridAAH-1420-2021
dc.contributor.researcheridCAV-8845-2022
dc.contributor.researcheridCYM-0930-2022
dc.contributor.researcheridGEG-1913-2022
dc.contributor.researcheridDJS-4895-2022
dc.contributor.researcheridCKK-3621-2022
dc.contributor.researcheridAAP-9988-2020
dc.date.accessioned2024-07-26T06:22:03Z
dc.date.available2024-07-26T06:22:03Z
dc.date.issued2018-03-01
dc.descriptionBu çalışma, 05-07, Mart 2018 tarihlerinde Paris[Fransa]’da düzenlenen International Congress on Targeted Anticancer Therapies (TAT) Kongresi‘nde bildiri olarak sunulmuştur.
dc.identifier.eissn1569-8041
dc.identifier.issn0923-7534
dc.identifier.urihttps://hdl.handle.net/11452/43460
dc.identifier.volume29
dc.identifier.wos000427179500101
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.journalAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectOncology
dc.titleMicrorna dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics
dc.typeMeeting Abstract
dspace.entity.typePublication

Files

Collections

Yeni Yayınlar